Cargando…
Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
This cross-sectional study of data from the National Comprehensive Cancer Network assesses the association of prostate-specific membrane antigen positron emission tomography with tumor upstaging risk in patients with high-risk prostate cancer.
Autores principales: | Brant, Aaron, Lewicki, Patrick, Xiang, Michael, Zhu, Alec, Kishan, Amar U., Pollom, Erqi Liu, Shoag, Jonathan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468886/ https://www.ncbi.nlm.nih.gov/pubmed/36094506 http://dx.doi.org/10.1001/jamanetworkopen.2022.31101 |
Ejemplares similares
-
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
por: Xiang, Michael, et al.
Publicado: (2021) -
Diagnostic performance of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography in intermediate and high risk prostate cancer
por: El Hajj, Albert, et al.
Publicado: (2019) -
Ga-68 Prostate-Specific Membrane Antigen-HBED-CC Positron Emission Tomography/Computed Tomography in Anaplastic Thyroid Carcinoma
por: Subudhi, T. Kishan, et al.
Publicado: (2022) -
Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021) -
Initial risk stratification and staging in prostate cancer with prostatic-specific membrane antigen positron emission tomography/computed tomography: A first-stop-shop
por: Gupta, Manoj, et al.
Publicado: (2018)